Medicines and Health Notices




11 AUGUST 2005

NEW ZEALAND GAZETTE, No. 123


Product: Hepsera
Active Ingredient: Adefovir dipivoxil 10mg
Dosage Form: Tablet
New Zealand Sponsor: Muir Hutchison Limited
Manufacturer: Patheon Inc, Mississauga, Ontario, Canada

Product: Lemoxol
Active Ingredient: Ceftazidime pentahydrate 1,160mg equivalent to ceftazidime 1,000mg
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Demo SA, Athens-Lamia, Kryoneri, Athens, Greece

Product: Lemoxol
Active Ingredient: Ceftazidime pentahydrate 2,320mg equivalent to ceftazidime 2,000mg
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Demo SA, Athens-Lamia, Kryoneri, Athens, Greece

Product: Paracetamol
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: BJM Distributors Limited
Manufacturer: Strides Arcolab Ltd, Indlawadi Cross, Anekal Taluk, Bangalore, India

Dated this 29th day of July 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5214


Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product: Vicks VapoDrops Fresh Peppermint
Active Ingredients: Menthol 7.14mg
Peppermint oil 7.14mg
Dosage Form: Lozenge
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Makson Health Care (Private) Limited, Mandideep, Raison District, Madya Pradesh, India

Dated this 5th day of August 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5217


Mental Health (Compulsory Assessment and Treatment) Act 1992

Mental Health (Compulsory Assessment and Treatment) Act Notice 2005—Appointment of Directors of Area Mental Health Services

Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Karen Olive Poutasi, Director-General of Health, give the following notice.

Notice

  1. This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Act Notice 2000—Appointment of Directors of Area Mental Health Services (“the principal notice”)*.

  2. The Schedule to the principal notice is amended in respect of

"Area 7—Waikato"

by omitting the name and title

"Dr John Strachan, consultant psychiatrist, of Waikato"

and substituting the name and title

"Dr Jamshed Meher-Homji, consultant psychiatrist, of Hamilton."

Dated at Wellington this 4th day of August 2005.

KAREN O. POUTASI (DR), Director-General of Health.

*New Zealand Gazette, 31 August 2000, page 2963

go5205



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 123


Gazette.govt.nz PDF NZ Gazette 2005, No 123





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
29 July 2005
Medicines Act, Hepsera, Lemoxol, Paracetamol, Distribution Consent, Health Regulations
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of a New Related Product

🏥 Health & Social Welfare
5 August 2005
Medicines Act, Vicks VapoDrops Fresh Peppermint, Distribution Consent, Health Regulations
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Appointment of Directors of Area Mental Health Services

🏥 Health & Social Welfare
4 August 2005
Mental Health Act, Waikato, Director Appointment, Consultant Psychiatrist
  • John Strachan (Doctor), Removed as Director of Area Mental Health Services
  • Jamshed Meher-Homji (Doctor), Appointed as Director of Area Mental Health Services

  • KAREN O. POUTASI (DR), Director-General of Health